Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Kingchem
301509
5
Hunan Er-kang Pharmaceutical
300267
US Stock MarketDetailed Quotes
SHPH Shuttle Pharmaceuticals
- 0.3017
- +0.0506+20.15%
Close Apr 23 16:00 ET
- 0.2932
- -0.0085-2.82%
Pre 08:00 ET
1.89MMarket Cap-0.09P/E (TTM)
0.3069High0.2521Low2.57MVolume0.2890Open0.2511Pre Close727.56KTurnover46.28%Turnover RatioLossP/E (Static)6.26MShares4.710452wk High2.67P/B1.68MFloat Cap0.230052wk Low--Dividend TTM5.55MShs Float1010.0800Historical High--Div YieldTTM21.82%Amplitude0.2300Historical Low0.2830Avg Price1Lot Size
About Shuttle Pharmaceuticals Company
Shuttle Pharmaceuticals Holdings, Inc. is a clinical stage pharmaceutical company, which engages in the development of novel therapies for cancer. It also offers cancer treatments with surgery, radiation therapy, chemotherapy, and immunotherapy. The company was founded by Anatoly Dritschilo, Mira Jung, and Milton Brown on December 18, 2012 and is headquartered in Gaithersburg, MD.
Company Profile
SymbolSHPH
Company NameShuttle Pharmaceuticals
Listing DateAug 31, 2022
Issue Price8.12
Founded2012
CEOMr. Christopher R. Cooper
MarketNASDAQ
Employees9
Fiscal Year Ends12-31
Address401 Professional Drive,Suite 260
CityGaithersburg
ProvinceMaryland
CountryUnited States of America
Zip Code20879
Phone1-240-403-4212
Websitehttp://www.shuttlepharma.com
Company Executives
- Name
- Position
- Salary
- Christopher R. Cooper
- Interim Chief Executive Officer
- --
- Timothy J. Lorber
- Chief Financial Officer and Principal Accounting Officer
- 197.64K
- Peter Dritschilo
- President and Chief Operating Officer
- 236.00K
- Dr. Tyvin A. Rich, M.D.
- Chief Clinical Officer
- 218.00K
- Dr. Mira Jung, M.A.,PhD
- Chief Scientific Officer
- --
- Dr. Anatoly Dritschilo, M.D.
- Chairman of the Board and Chief Scientific Officer
- 274.00K
- Oleh Nabyt
- Director
- --
- Joseph Tung
- Director
- --
- George Scorsis
- Director
- --
- Steven Richards, C.P.A.
- Independent Director
- --
Market Insights
Discussing
2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current
Moomoo News Global
Apr 9 20:29
Learning From Buffett: Investing Wisely Amid Market Volatility Triggered by Trump's Tariffs
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
